MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma

News   May 08, 2015

 
MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma
 
 
 

RELATED ARTICLES

LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target Discovery

News

LifeArcĀ®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

READ MORE

New Rare Antibody Isolation Strategy

News

A strategy for rapidly isolating rare, naturally occurring antibodies is reported this week. The strategy could aid in developing biological therapeutics and vaccines in the future.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE